Waters

WAT · NYSE

$442.83+$8.56 (+1.97%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $434.27

Latest news

Press releaseOct 20, 8:00 AM ETPRNewswire
Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
Press releaseOct 19, 3:08 AM ETBusiness Wire
IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease
Press releaseOct 13, 8:00 AM ETPRNewswire
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
NewsOct 7, 10:06 AM ETPiero Cingari
Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth
NewsOct 6, 3:29 PM ETPiero Cingari
The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited
Press releaseOct 1, 9:00 AM ETPRNewswire
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
Press releaseSep 14, 8:00 AM ETPRNewswire
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Press releaseSep 11, 9:00 AM ETPRNewswire
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
Press releaseAug 26, 9:00 AM ETPRNewswire
Waters Corporation to Present at the Wells Fargo Healthcare Conference
NewsAug 4, 6:02 AM ET
Waters Q2 Adj. EPS $3.05 Beats $3.01 Estimate, Sales $1.645B Beat $1.623B Estimate
Press releaseAug 4, 6:00 AM ETPRNewswire
Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
Press releaseJul 27, 8:10 AM ETPRNewswire
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
Press releaseJul 2, 6:00 AM ETPRNewswire
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
Press releaseJun 24, 8:00 AM ETBusiness Wire
IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
Press releaseJun 9, 8:00 AM ETPRNewswire
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
Press releaseJun 8, 8:00 AM ETPRNewswire
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Press releaseJun 3, 8:00 AM ETPRNewswire
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
Press releaseJun 1, 8:00 AM ETPRNewswire
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
Press releaseJun 1, 8:00 AM ETPRNewswire
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research
Press releaseMay 18, 4:00 PM ETPRNewswire
Waters Corporation to Present at the Jefferies Global Healthcare Conference
NewsMay 5, 1:33 PM ETPiero Cingari
Nasdaq 100 Tops 28,000, Intel Rallies 13%: Stock Market Today
NewsMay 5, 7:12 AM ET
Earnings Scheduled For May 5, 2026
NewsMay 5, 6:03 AM ET
Waters Q1 Adj. EPS $2.70 Beats $2.34 Estimate, Sales $1.267B Beat $1.203B Estimate
Press releaseMay 5, 6:00 AM ETPRNewswire
Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results
Press releaseApr 20, 4:15 PM ETPRNewswire
Waters Corporation Schedules First Quarter 2026 Earnings Conference Call
Press releaseApr 14, 8:00 AM ETPRNewswire
Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules
Press releaseApr 8, 8:00 AM ETPRNewswire
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay
Press releaseMar 18, 6:00 AM ETPRNewswire
Waters Prices Offering of Senior Notes
Press releaseMar 9, 8:00 AM ETPRNewswire
Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
Press releaseFeb 23, 4:45 PM ETPRNewswire
Waters Corporation to Present at the TD Cowen Health Care Conference
Press releaseFeb 17, 8:00 AM ETPRNewswire
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage
NewsFeb 10, 10:00 AM ET
Reports Q 2026 Results: Full Earnings Call Transcript
Press releaseFeb 9, 8:40 AM ETPRNewswire
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation
NewsJan 27, 9:28 AM ET
Waters Shareholders Approve Proposed Combination Of Becton, Dickinson and Company's Biosciences & Diagnostic Solutions Operations With Waters
NewsJan 6, 1:48 PM ETVandana Singh
Waters-Becton Dickinson Deal May Deliver Bigger Gains Than Expected: Analyst
NewsNov 6, 1:11 PM ETVandana Singh
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease

Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth

The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Waters Q2 Adj. EPS $3.05 Beats $3.01 Estimate, Sales $1.645B Beat $1.623B Estimate

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Waters Corporation to Present at the Jefferies Global Healthcare Conference

Nasdaq 100 Tops 28,000, Intel Rallies 13%: Stock Market Today

Earnings Scheduled For May 5, 2026

Waters Q1 Adj. EPS $2.70 Beats $2.34 Estimate, Sales $1.267B Beat $1.203B Estimate

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

Waters Corporation to Present at the TD Cowen Health Care Conference

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Reports Q 2026 Results: Full Earnings Call Transcript

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

Waters Shareholders Approve Proposed Combination Of Becton, Dickinson and Company's Biosciences & Diagnostic Solutions Operations With Waters

Waters-Becton Dickinson Deal May Deliver Bigger Gains Than Expected: Analyst

Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal